US2022243176A1PendingUtilityA1
Specific selection of immune cells using versatile display scaffolds
Est. expiryMay 31, 2039(~12.8 yrs left)· nominal 20-yr term from priority
B03C 1/02C07K 16/00C07K 14/445C07K 14/00G01N 33/56972C12N 5/0634
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are compositions and methods for use in isolating cells responsive to a target protein by first contacting a collection of isolated cells in an in vitro sample to a complex and then isolating the complex. The complex is formed from a target protein with a capture tag coupled to a multimeric protein structure of at least two self-assembled copies of a monomeric protein substructure fused with a capture sequence.
Claims
exact text as granted — not AI-modified1 . A method for isolating cells responsive to a target protein comprising:
(a) contacting a collection of isolated cells in an in vitro sample to a complex, the complex comprising a target protein with a capture tag coupled to a multimeric protein structure of at least two self-assembled copies of a monomeric protein substructure fused with a capture sequence and optionally a linker and incubating therewith; and, (b) isolating the complex.
2 . The method of claim 1 , wherein the monomeric protein substructure is further fused with a complementary affinity sequence.
3 . The method of claim 2 , wherein the complementary affinity sequence is a biotin tag.
4 . The method of claim 2 , wherein step (b) is performed by introducing beads affixed with the complementary binding partner to the complementary affinity sequence and isolating the beads.
5 . The method of claim 4 , wherein the complementary binding partner is avidin or streptavidin.
6 . The method of claim 1 , further comprising before (b) incubating the complex with an antibody, wherein the antibody is biotinylated and binds to the monomeric protein substructure.
7 . The method of claim 6 , wherein step (b) is performed by introducing beads affixed with avidin to the in vitro solution and isolating the beads.
8 . The method of claim 4 , wherein the beads are magnetic.
9 . (canceled)
10 . The method of claim 1 , wherein the monomeric protein substructure has at least 85% sequence identity with an amino acid selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3.
11 . The method of claim 1 , wherein the capture sequence has at least 85% sequence identity with an amino acid selected from the group consisting of SEQ ID NO: 7, SEQ ID NO: 8 or SEQ ID NO: 9.
12 . The method of claim 1 , wherein the monomeric protein substructure is further fused with a fluorophore.
13 . The method of claim 12 , wherein the monomeric protein substructure has at least 85% sequence identity with an amino acid selected from the group consisting of SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 or SEQ ID NO: 19.
14 . The method of claim 1 , wherein the capture tag has at least 90% sequence identity with an amino acid selected from the group consisting of SEQ ID NO: 26 or SEQ ID NO: 27.
15 . The method of claim 4 , further comprising isolating cells bound to the complex by flow cytometry.
16 . The method of claim 1 , wherein the collection of cells comprise adaptive immune cells.
17 . (canceled)
18 . (canceled)
19 . The method of claim 1 , further comprising isolating nucleic acids from cells associated with the complex in (b).
20 . The method of claim 1 , further comprising isolating a nucleic acid encoding an antibody after (b).
21 . (canceled)
22 . The method of claim 1 , wherein the sample further comprises a second complex, the second complex featuring a second target protein different from the first.
23 . (canceled)
24 . A method for assaying a subject for immunity to a target protein comprising:
(a) incubating a collection of cells isolated from the subject in an in vitro solution with a complex, the complex comprising a target protein with a capture tag coupled to a multimeric protein structure of at least two self-assembled copies of a monomeric protein substructure fused with a capture sequence and a linker and incubating therewith; and, (b) measuring the complex and analyzing for associated proteins.
25 . A method for preparing a B cell in vitro tissue culture with binding affinity to a target protein comprising:
(a) incubating a collection of cells comprised of B cells in an in vitro solution with a complex, the complex comprising a target protein with a capture tag coupled to a multimeric protein structure of at least two self-assembled copies of a monomeric protein substructure fused with a capture sequence and a linker and incubating therewith; (b) isolating the complex; (c) isolating B cells from the complex; and (d) transferring isolated B cells from (c) to a tissue culture medium.
26 .- 51 . (canceled)Join the waitlist — get patent alerts
Track US2022243176A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.